920113-02-6|P276-00,P276-00 is an analog of flavopiridol where the piperidine moiety has been changed for a pyrrolidine and resulted from an intense structure-activity and co-crystallization effort [24,46,47]. P276-00 inhibits efficiently CDK9 (IC50: 20 nM), but also other CDKs such as CDK1 (IC50: 79 nM), CDK2 (IC50: 224 nM) and CDK4 (IC50: 63 nM). The development is being performed by Nicholas Piramal Company and phase II clinical trials for various types of tumours have been announced (e.g., recurrent and/or locally advanced head and neck cancer, relapsed and/or refractory mantle cell lymphoma). Although several phase II trials ended in 2012/2013 no results could be found.
Copyright © 2014-2015 Tubepharm. All Rights Reserved.
Tel：+86 021 5433 8626 Fax：+86 021 5433 8626*801 E-mail: email@example.com
All of our products, unless clearly indicated otherwise, are sold for research or manufacturing purposes only, are not for human, veterinary and household use.
The products under valid patent protection are not offered at this time. It is fully client's responsibility to comply with the rules, regulations and patent laws.